The Senate continues to hammer away at passing President Trump’s “Big Beautiful Bill,” working through the weekend and holding a vote-a-rama session on Monday.
If and when it passes, the House would need to approve the Senate’s changes to the reconcil…
Health and Human Services Secretary Robert F. Kennedy Jr. has said the United States will cease making contributions to Gavi, a global alliance that works to expand vaccine access for children in impoverished areas, accusing them of “ignoring the scien…
Dr. Patrick Conway, who was named CEO of Optum in May, is also taking on the position of leading Optum Health, according to a statement from the company.
UnitedHealth Group subsidiary Optum is launching AI Marketplace, a healthcare-specific artificial intelligence platform that’s meant to accelerate AI adoption among payers, providers and healthcare technology companies.
The new marketplace seeks to sim…
Healthcare finance leaders have expressed concern about industry regulations and the economy, with 84% in a new Deloitte survey saying they’re concerned about business conditions stemming from potential policy changes and disruptions linked to tariffs …
Healthcare merger and acquisition deal volumes have remained steady despite an uncertain regulatory environment, with volumes pacing far ahead of where they were before the COVID-19 pandemic.
AdvancedMD and NGA Healthcare have partnered to help independent medical practices get higher reimbursement rates from payers.
This week, providers and other stakeholders are coming out in force in asking legislators to protect Medicaid.
Ahead of an expected vote in the Senate on the “Big Beautiful Bill,” the American Hospital Association has launched an ad urging Congress to …
A group of medical societies and physician groups has sent a letter to senators saying that a fix to the Medicare Physician Fee Schedule that was passed in the House version of the reconciliation bill should be included in the Senate draft.
Overpaying for GLP-1 medications is extremely common, with a new data analysis of 102,166 drugs showing that 92% of those prescriptions could have been filled at a lower price.
The DoseSpot analysis estimated that if the prescriptions had been filled a…
